Saint No Pharmaceutical-B (02257.HK) has submitted a summons to the court, accusing several former members of the group's management, including Lu Yang, Dai Xiaochang, and Ye Yongji.

Zhiyt Finance APP News, Shengnuo Pharmaceutical-B (02257.HK) announced that on August 14, 2026, the company and its directly wholly-owned subsidiary Shengnuo (Hong Kong) Limited (collectively referred to as "Plaintiffs") submitted a summons to the High Court of the Hong Kong Special Administrative Region (Court) (Case No.: HCA1427/2026) against certain former management of the Group, including Dr. Lu Yang, Dr. Dai Xiaochang, and Mr. Ye Yongji (collectively referred to as "Defendants").